{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY  TO EVALUATE PF-08046054\/SGN-PDL1V VERSUS  DOCETAXEL IN ADULT PARTICIPANTS WITH  PREVIOUSLY-TREATED PROGRAMMED CELL  DEATH LIGAND 1 (PD-L1) POSITIVE  NON-SMALL-CELL LUNG CANCER (NSCLC)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-randomized-phase-3-open-label-study-to-evaluate-pf-08046054-sgn-pdl1v-versus-docetaxel-in-adult-participants-with-previously-treated-programmed-cell-death-ligand-1-pd-l1-positive-non-small\/#breadcrumbitem"}]}